OliX is a South Korea-based pharmaceutical company that develops and markets RNAi therapeutics for the treatment of age-related macular degeneration diseases.
Business Model:
Revenue: $3.1M
Employees: 51-200
Address: 17, Daehak 4-ro, Yeongtong-gu
City: Suwon-si
State: gyeonggido
Zip: 16226
Country: KR
OliX is a South Korea-based pharmaceutical company that develops and markets RNAi therapeutics for the treatment of age-related macular degeneration diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Korea Exchange
IPO Date:
7/20/2018
Ticker Symbol:
226950
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Post-IPO Equity | $45M |
KB Investment IMM Investment Corp. Company K Partners Solidus Investment Co., Ltd Susung Asset Management Co., Ltd. Welcome Asset Management Focus Asset Management Shinhan Capital |
11/2020 | Post-IPO Equity | $37.2M |
Kiwoom Investment Aju IB Investment |
7/2018 | IPO | - | 12/2020 | Post-IPO Equity | 4 | $37.5M |
Aju IB Investment Kiwoom Investment NH Investment &a; Securities Widwin Investment Aju IB Investment Kiwoom Investment NH Investment &a; Securities Widwin Investment |
7/2018 | IPO | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|